Professor, Department of Neurosurgery
University of Alabama at Birmingham
Van Meir has developed novel therapeutic approaches for cancer using oncolytic adenoviruses and anti-angiogenic molecules and is currently developing novel small molecule inhibitors of the hypoxia-inducible factor pathway. His research aims to translate these novel agents to testing in clinical trials with the hope to develop novel medicines for cancer treatment.
Children's of Alabama
Medulloblastomas comprises the vast majority of pediatric embryonal tumors and by definition arise in the posterior fossa, where they constitute approximately 40% of all posterior fossa tumors. Other forms of embryonal tumors each make up 2% or less of all childhood brain tumors.The clinical feature